noetic quality of mystical experiences, 41 –42, 69 –70, 275 , 285 , 305 –6
The Noonday Demon (Solomon), 383
Novak, Steven, 158
Nutt, David
background of, 299 –300
and Carhart-Harris’s research, 295 –96, 297 , 300
on comparative risks of drugs, 299 –300, 300n
and depression pilot study, 329
Drugs Without the Hot Air, 300n
on repression, 307
obsessive-compulsive disorder
and ego’s tyranny, 367
and excess of order in brain, 313 , 329 , 385
and negative thinking habits, 383
and psycholytic LSD therapy, 156
ololiuqui (seeds of the morning glory), 107
Olson, Frank, 172
openness to experience
and ego dissolution, 316n
longterm changes in, 74 , 319 –20
in Pollan’s psychedelic journeys, 135 , 137 , 222 , 252
opiates, 212 , 369n
Osmond, Humphry
ambitions of, 194
and Commission for the Study of Creative Imagination, 174
and Hubbard, 168 –69, 170 , 174 , 200
and Huxley, 160 , 174
and Leary, 198 –99, 198n
and LSD therapy for alcoholism, 148 –52, 170
and mescaline, 146 –47
and psychedelic therapy paradigm, 160 , 163 , 169 , 207
and “psychedelics” term, 160 , 162 –63
and “psychodelytic” term, 199
and psychotomimetic model, 162 , 169
and reunion of first wave figures, 219 , 220
and role of environment, 151
schizophrenia research of, 146 –47
Ott, Jonathan, 25 , 101 , 103
overdosing with psychedelics, 14
overview effect, 359 –60, 366 , 375 , 380 , 389
Pahnke, Walter
and Good Friday (Marsh Chapel) Experiment, 45 –46, 80 –81, 191 –92
on modes of consciousness, 409n
and mystical experience survey, 282
and Richards, 53 , 54 –55
at Spring Grove, 57 , 218
paranoia, 310